enVVeno Medical Corporation (NVNO)

NASDAQ: NVNO · Real-Time Price · USD

10.61

+0.46 (4.57%)

At close: Aug 7, 2026, 4:00 PM EDT

10.81

+0.20 (1.84%)

After-hours: Aug 7, 2026, 7:48 PM EDT

enVVeno Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2.84	3.07	1.75	3.62	4.56	54.73
Short-Term Investments	18.65	25.15	41.4	42.79	34.49	-
Cash & Short-Term Investments	21.49	28.21	43.15	46.41	39.04	54.73
Cash Growth	-38.86%	-34.62%	-7.02%	18.87%	-28.66%	486.29%
Other Current Assets	0.6	0.61	0.58	0.51	0.39	0.31
Total Current Assets	22.08	28.83	43.73	46.92	39.44	55.04
Net Property, Plant & Equipment	0.55	0.71	1.19	1.68	2.19	2.61
Other Long-Term Assets	0.03	0.03	0.03	0.03	0.03	0.05
Total Assets	22.66	29.56	44.95	48.64	41.66	57.7
Accounts Payable	1.49	1.73	1.73	1.03	1.22	0.56
Accrued Expenses	-	-	-	-	-	0.73
Current Portion of Leases	0.4	0.39	0.36	0.34	0.31	0.29
Total Current Liabilities	1.89	2.12	2.1	1.37	1.53	1.58
Long-Term Leases	0.1	0.31	0.7	1.06	1.4	1.72
Total Long-Term Liabilities	0.1	0.31	0.7	1.06	1.4	1.72
Total Liabilities	1.99	2.43	2.8	2.44	2.93	3.3
Additional Paid-in Capital	199.45	198.46	194.01	176.24	145.25	136.26
Retained Earnings	-178.78	-171.33	-151.86	-130.04	-106.52	-81.85
Shareholders' Equity	20.67	27.13	42.16	46.2	38.73	54.4
Total Liabilities & Equity	22.66	29.56	44.95	48.64	41.66	57.7
Total Debt	0.51	0.7	1.06	1.4	1.72	2.01
Net Cash (Debt)	20.98	27.51	42.09	45.01	37.33	52.72
Net Cash Growth	-38.76%	-34.63%	-6.49%	20.58%	-29.20%	523.64%
Net Cash Per Share	33.33	46.71	85.90	128.07	116.34	212.59
Book Value	20.67	27.13	42.16	46.2	38.73	54.4
Book Value Per Share	32.83	46.06	86.04	131.46	120.71	219.37
Tangible Book Value	20.67	27.13	42.16	46.2	38.73	54.4
Tangible Book Value Per Share	32.83	46.06	86.04	131.46	120.71	219.37

SEC Filings: 10-K · 10-Q